Merit Medical Systems | MMSI

Stock Price
92.97
Daily Change
0.82 0.89%
Monthly
11.27%
Yearly
-3.74%
Q3 Forecast
92.20

Peers Price Chg Day Year Date
Terumo 2,645.50 20.00 0.76% -0.02% Sep/05
Olympus 1,872.00 72.00 4.00% -25.99% Sep/05
Abbott 132.94 0.13 0.10% 16.68% Sep/05
AtriCure 35.38 -0.28 -0.79% 34.83% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Cooper Companies 68.09 0.09 0.13% -36.13% Sep/05
Dexcom 80.51 -0.25 -0.31% 17.11% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Globus Medical 60.60 0.31 0.51% -13.42% Sep/05
Haemonetics 54.38 0.30 0.55% -25.75% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
ICU Medical 131.24 5.61 4.47% -19.15% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Medtronic 92.93 0.13 0.14% 3.32% Sep/05
3M 155.30 -0.22 -0.14% 20.62% Sep/05
Merit Medical Systems 92.97 0.82 0.89% -3.74% Sep/05
Pfizer 24.88 0.34 1.39% -12.95% Sep/05
Insulet 348.43 1.96 0.57% 62.25% Sep/05
STAAR Surgical 27.94 0.16 0.58% -10.22% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Tandem Diabetes Care 12.58 0.19 1.53% -70.33% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
USND 21700 -7.31 -0.03% 30.01% Sep/05
US2000 2391 11.44 0.48% 14.33% Sep/05

Merit Medical Systems traded at $92.97 this Friday September 5th, increasing $0.82 or 0.89 percent since the previous trading session. Looking back, over the last four weeks, Merit Medical Systems gained 11.27 percent. Over the last 12 months, its price fell by 3.74 percent. Looking ahead, we forecast Merit Medical Systems to be priced at 92.20 by the end of this quarter and at 89.92 in one year, according to Trading Economics global macro models projections and analysts expectations.

Merit Medical Systems, Inc. designs, develops, manufactures and markets medical products for interventional and diagnostic procedures. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.